Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

Most of us use methylphenidate (MPH) routinely in patients across a wide range of ages and even diagnoses. But what are the long-term side effects of MPH? This research update gives you a current understanding of the potential risks with helpful guidance on how to proceed with care.

Learn about the risks and efficacy of gepirone (Exxua) for treating MDD.

When we must use antipsychotics (NbN D2 receptor blockers), we do whatever we can to avoid side effects from them. This research upside looks at the potential for the new olanzapine-semiglutide combination medication to reduce D2 blocker-related weight gain in children and teens.

How do lithium and quetiapine compare in their ability to treat acute mania in children and teens? Are they effective? Do kids go into remission? And how do their side effect profiles compare?  This clinical update can help you decide which patients might be good candidates for which medication. 

You want to protect your manic child or teen patient from metabolic problems associated with most antipsychotics, so you think about using ziprasidone. How likely is it to work? Is it truly well tolerated? We give you our best take on it despite the problems inherent in industry-funded research. 

Few medications are as complex to use as clozapine. This guide will equip you with the necessary knowledge and insights to prescribe it, monitor for side effects, and recognize key risks.